Lorcaserin not approved by the FDA due to weight loss of only 3% and an increased cancer in rats

Posted by .(JavaScript must be enabled to view this email address)
Saturday, October 23, 2010 9:01 am Email this article
The diet pill lorcaserin was not approved by the U.S. Food and Drug Administration (FDA) after an advisory panel voted 9-5 against recommending approval since weight loss was only 3 percent more than with a placebo and the drug was linked to cancer in rats.

The FDA notes that more studies are need to weigh the benefits versus risks. REFERENCE

Larkin C. Arena’s lorcaserin diet pill rejected by fda on concern over cancer risk. Bloomberg. 2010 Oct 23, 9:33 AM PT, http://www.bloomberg.com/news/2010-10-23/arena-s-lorcaserin-diet-pill-rejected-by-fda-on-concern-over-cancer-risk.html

Articles on the same subject can be found here:

• Lorcaserin (also see Belviq (lorcaserin hydrochloride))